A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Yemm, Kristyn E; Barreto, Jason N; Mara, Kristin C; Dierkhising, Ross A; Gangat, Naseema; Tosh, Pritish K.
J Antimicrob Chemother
; 73(1): 204-211, 2018 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-29040595
Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
[Efficacy of Levofloxacin Hydrate in Febrile Neutropenia for Outpatient Chemotherapy].
Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
Risk-stratification management of febrile neutropenia in pediatric hematology-oncology patients: Results of a French nationwide survey.
[Comparison of garenoxacin and levofloxacin for the prophylaxis of febrile neutropenia].
Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.
Prognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.
[Overview of guidelines for proper use of the G-CSF(2013 edition)].
[Breast and Endocrine Tumor Supportive Care for Febrile Neutropenia in Chemotherapy - Current Situation and Future Perspective in Breast Cancer Treatment -].
Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.